Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), ...
Well, maybe you could, but Bill didn't. This story actually goes back to 2004, when it was reported by German publication PC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback